Pure Autonomic Failure (PAF)
1 clinical trials · Condition
◉ Watch Pure Autonomic Failure (PAF)
| Record | Firm | Date |
|---|---|---|
| Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (NCT03829657) | Theravance Biopharma | 2019-02-22 |
Track Pure Autonomic Failure (PAF) automatically
Every clearance here is in the API, with alerts when new ones post.